[Skip to Content]

Research Faculty

Adekola Alao
Adekola Alao, MD
Clinical Professor

Research Interests

Mind-body interface, chronic pain, sickle cell disease

Kevin Antshel
Kevin Antshel, PhD
Clinical Assistant Professor

Research Interests

Acquired/developmental learning disorders, childhood peer relations, brain:behavior relations, ADHD, Autism Spectrum Disorders

Charles Bradshaw
Charles Bradshaw, PhD
Clinical Associate Professor

Research Interests

FMRI and SPECT localization of neuropsychological functions, memory functions and prosody

Robert Daly

Research Interests

The conceptual foundations of psychiatry, philosophy of medicine, ethics, psychoanalysis

Mantosh Dewan
Mantosh Dewan, MD
Distinguished Service Professor

Research Interests

Treatment issues in schizophrenia:  economics of health care.

Stephen Faraone
Stephen Faraone, PhD
Distinguished Professor

Research Interests

Professor Faraone has been studying attention deficit hyperactivity disorder (ADHD) for three decades.  This topic has been of much interest to him because of the disorder’s high prevalence, its association with marked distress and disability in childhood and adulthood and its personal impact on my family.  His research has several foci. One line of work seeks to discover new biological pathways that will, eventually, improve the diagnosis and treatment of the disorder. To achieve this goal, he has been coordinating an international network of researchers that has discovered several genes that cause the disorder.  He his also conducting in depth studies of the SLC9A9 gene to better understand its functioning and how it’s disruption leads to neurodevelopmental disorders such as ADHD and autism. Because ADHD is also associated with aggressive behavior, substance use disorders and mood/anxiety disorders, Prof Faraone is studying the genetics of these comorbidities along with methods to predict which ADHD youth are at highest risk for these disorders. Information and results from these studies are disseminated via scientific publications, https://scholar.google.com/citations?user=PtJmhRwAAAAJ, and via http://adhdinadults.com/, for which he is Program Director as well as at https://adhdscreeneronline.com/.

Wanda Fremont

Research Interests

Biomarkers for Psychosis in Velocardiofacial Syndrome (NIMH Grant)

Child Psychiatric Diagnosis & Treatment by Primary Care Providers

Stephen Glatt

Research Interests

Dr. Glatt is Director of the Psychiatric Genetic Epidemiology & Neurobiology Laboratory (PsychGENe Lab).  The mission of the PsychGENe Lab is to develop and apply methods for finding the causes of mental health and mental illness.  The vision of the lab is that we will discover those causes and use that information to design interventions that treat or prevent these disorders, or foster resilience to them.  We are running numerous research projects aimed at finding the genes and environmental risk factors for a wide variety of disorders, including schizophrenia, bipolar disorder, post-traumatic stress disorder, autism spectrum disorder, and substance abuse disorders, among others.  Our pipeline seeks to identify “risk genes” for these disorders by studying affected individuals and families and then to reveal how such genes alter brain biology leading to a vulnerability to mental illness.

Roger Greenberg
Roger Greenberg, PhD
Distinguished Teaching Professor

Research Interests

Comparative efficacy of psychotherapy and medication treatments. Psychodynamics and personality.

Robert Gregory

Research Interests

Borderline personality disorder, addictions, neuroscience, psychotherapy

Brian Johnson

Research Interests

The goal of Dr. Johnson’s research is to understand how opioids exert their effects by addressing clinical challenges that appear unrelated but are unified by an innovative theory.  We propose a theory that unifies the nature of these disorders by assuming that each involves a dysregulation of the opioid system based on data suggesting that opioid dependence and fibromyalgia are associated with low opioid tone whereas autism is associated with high opioid tone.  Our first challenge, therefore, is to create and validate a treatment for opioid dependence that corrects persistent hormonal changes after detoxification.  Our second challenge is to treat fibromyalgia.  Our third challenge is to assess whether autism is a disease of too-high opioid tone by blocking excess opioid stimulation to treat the symptoms.  Opioid dependence, fibromyalgia, and autism are three disorders that cause much distress and disability but are difficult to treat.  We test our theory by treating opioid dependence and fibromyalgia with low-dose naltrexone and autism with high-dose naltrexone.  Our theory suggests a novel approach that could improve the quality of life of patients suffering from these debilitating disorders.

James Knoll
James Knoll, MD
Clinical Professor
Chunyu Liu
Chunyu Liu, PhD

Research Interests

Dr. Liu's major research focuses on identifying the molecular mechanisms of major psychiatric diseases, particularly bipolar disorder and schizophrenia using  comprehensive approaches including genetics, bioinformatics, genomics, cellular and animal models.

Leslie Major
James Megna

Research Interests

Epidemiology/pharmacotherapy of schizophrenia; Ego strength among inpatients & its relation to engagement in treatment; cardiovascular risk factors in patients with serious mental illness; changes in cognition in response to depression treatment

Zsuzsa Szombathyne Meszaros

Research Interests

Smoking and alcohol use disorders commonly occur together.  People who drink alcohol are three times more likely to smoke, and smokers are four times more likely than the general population to be dependent on alcohol.  When nicotine and alcohol dependence occur together, the health risks are increased, and the chances of quitting smoking and drinking are lower.  The exact mechanism of co-occurring nicotine and alcohol dependence is not clearly understood.  In everyday clinical practice, interventions used for smoking cessation are not combined with treatment of alcohol dependence.  Our clinical research program is focused on developing new medications to treat alcohol and nicotine dependence simultaneously.  Two investigational new drugs recently tested at our division decreased drinking and/or smoking severity and prevented cognitive problems associated with smoking and drinking.  Our goal is to establish the safety and efficacy of these neuroprotective agents in different patient populations.  Preventing cognitive decline is of great importance to inpatients with addiction.  Development of new, neuroprotective medications may reduce harm associated with heavy smoking and alcohol use.

Christopher Morley
Christopher Morley, PhD, MA
Associate Professor

Research Interests

Health Disparities, Medical Sociology, Med Education, Ethics, Research Methods, Behavioral Health, Genetics

Ronald Saletsky
Ronald Saletsky, PhD
Associate Professor

Research Interests

Adaptation to type 1 and type 2 diabetes in childhood, Children and foster care, Emotional development in children

Robbi Saletsky
Robbi Saletsky, PhD
Associate Professor
Usha Satish
Thomas Schwartz

Research Interests

One aspect of academic psychiatry and teaching is to cultivate medical students and residents and to steer them towards understanding and conducting clinical research.  In the Department of Psychiatry, Dr. Schwartz and his colleagues James Megna, M.D., Adekola Alao, M.D., and others, have strong track records of involving students and residents in research.  Students and residents routinely present posters at national meetings and have their work published in reputable journals.  Students and residents learn how to write case histories, case series, create and conduct surveys, analyze datasets collected by faculty, and occasionally conduct prospective trials.  We feel these fundamental research experiences are the gateway to launching careers in more in-depth and formal clinical research for our students and residents.  Fortunately, these research experiences can be developed for a fraction of the cost of starting a new research project, but nevertheless funding for such experiences cannot be easily obtained from typical funding streams, such as the U.S. National Institutes of Health.

Paula Trief
Paula Trief, PhD
Distinguished Service Professor

Research Interests

My research focuses on the psychosocial issues that affect patients with diabetes and those at risk for diabetes.  I have developed and tested effective and practical interventions for patients with diabetes, those at risk, and their partners, to help them achieve better physical health (e.g., control of blood sugar, weight) and quality of life.  I have also studied the relationship between depression/anxiety and diabetes outcomes. My current NIH-funded project follows young adults with type 2 diabetes to better understand factors that affect medication adherence and healthcare usage, to design more effective behavioral interventions for this vulnerable group. 

Wei-Dong Yao

Research Interests

Synaptic modulation and plasticity in prefrontal circuitry; molecular mechanisms of synapse formation, maturation, and stabilization; neurobiological basis of prefrontal-related neuropsychiatric and neurological diseases.

Emeritus Faculty

Dr. Wendy Kates
Dr. Wendy Kates, PhD
Emeritus Faculty

Research Interests:

Neurodevelopment and gene-brain-behavior interactions in children with genetic and developmental disorders, primarily 22q11.2 deletion syndrome and autism